Literature DB >> 30102813

Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma.

Harman S Parhar1,2, Elizabeth Gausden2, Jayendrakumar Patel2, Eitan Prisman1, Donald W Anderson1, J Scott Durham1, Barret Rush2,3.   

Abstract

BACKGROUND: As transoral robotic surgery (TORS) is being increasingly used to treat patients with oropharyngeal squamous cell carcinoma (OPSCC), there is an interest in determining contributors to readmission.
METHODS: We conducted this retrospective multivariate analysis modeling 30-day readmission using the Nationwide Readmissions Database (2012-2014).
RESULTS: Of 950 patients, 117 (12.3%) were readmitted. Hemorrhage and diet/aspiration accounted for 32.5% and 19.7% of readmissions, respectively. Of those readmitted, 23.1% required operative bleeding control, 11.1% required transfusion, 1.7% required tracheostomy, and 18.8% required gastrostomies. Those readmitted were older (mean 63.2 years, SD 9.5 vs 60.9 mean years, SD 10.3) and had longer hospitalizations (mean 5.7 days, SD 6.8 vs mean 4.3 days, SD 4.1) and higher rates of aspiration/pneumonia (9.4% vs 2.4%, P < .01) on index admission. Multivariate analysis demonstrated that aspiration/pneumonia on index admission was independently associated with readmission (OR 3.128, 95% CI 1.178-8.302).
CONCLUSIONS: Of the patients 12.3% were readmitted within 30 days with hemorrhage and diet complications as significant contributors.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  oropharyngeal cancer; patient safety; quality improvement; readmission; transoral robotic surgery

Mesh:

Year:  2018        PMID: 30102813     DOI: 10.1002/hed.25362

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.

Authors:  Lauren Ottenstein; Hannah Cornett; Jeffrey M Switchenko; Meghana Nathan; Susan Thomas; Amanda I Gillespie; Nancy McColloch; Tiffany Barrett; Matthew B Studer; Meghan Brinkman; Azeem S Kaka; Brian J Boyce; Robert L Ferris; Ashley H Aiken; Mark El-Deiry; Jonathan J Beitler; Mihir R Patel
Journal:  Head Neck       Date:  2021-02-05       Impact factor: 3.147

2.  [Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides].

Authors:  Alexander Fabian; David Krug
Journal:  Strahlenther Onkol       Date:  2020-02       Impact factor: 3.621

3.  Quantifying Tumor and Vasculature Deformations during Laryngoscopy.

Authors:  Xiaotian Wu; David A Pastel; Rihan Khan; Clifford J Eskey; Yuan Shi; Michael Sramek; Joseph A Paydarfar; Ryan J Halter
Journal:  Ann Biomed Eng       Date:  2022-01-07       Impact factor: 4.219

4.  Airway management during transoral robotic surgery for head and neck cancers: a French GETTEC group survey.

Authors:  Valentine Poissonnet; Emilien Chabrillac; Philippe Schultz; Sylvain Morinière; Philippe Gorphe; Bertrand Baujat; Renaud Garrel; Audrey Lasne-Cardon; Alexandre Villeneuve; Guillaume Chambon; Nicolas Fakhry; Karine Aubry; Xavier Dufour; Olivier Malard; Romina Mastronicola; Benjamin Vairel; Patrice Gallet; Philippe Ceruse; Franck Jegoux; Jean Ton Van; Guillaume De Bonnecaze; Sébastien Vergez
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-23       Impact factor: 2.503

5.  Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.

Authors:  Neha Wadhavkar; Jeffrey B Jorgensen; Craig A Bollig
Journal:  Head Neck       Date:  2022-04-29       Impact factor: 3.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.